top of page

Pathways Panel

The Problem:​

So far, success of precision medicine initiatives has been limited, why?​

  1. DNA-based, even though a DNA mutation does not imply downstream pathway activation​

  2. Focused only on one gene/one protein​

  3. Focused only on one molecular pathway​

​

Our Solution:​

A novel, multi-plexed, complementary diagnostic that integrates RNA and Protein information to determine pathway activation and identify the right targeted therapy for the right patient.​

 

Pathways.png
BTRC logo.png
SickKids-Logo.gif

Mailing Address

​

Arthur and Sonia Labatt Brain Tumour Research Centre

The Hospital for Sick Children

Peter Gilgan Centre for Research and Learning

686 Bay Street, 17-9702
Toronto, ON  M5G 0A4

Canada

​

bottom of page